Jansson-Knodell, Claire L.
King, Katherine S.
Larson, Joseph J.
Van Dyke, Carol T.
Murray, Joseph A.
Rubio-Tapia, Alberto
Funding for this research was provided by:
National Institute on Aging (R01AG034676)
National Institutes of Health (NIH R01-DK57892)
Article History
Received: 6 July 2017
Accepted: 1 November 2017
First Online: 10 November 2017
Compliance with ethical standards
:
: Joseph A. Murray (JAM) received grant support from National Institutes of Health, Alvine Pharmaceuticals, and Alba Therapeutics; received ongoing support from Oberkotter Foundation and Broad Medical Research Program at CCFA; serves on advisory board of Celimmune, LLC; was previous consultant to BioLineRx, GlaxoSmithKline (GSK), Genentech, and Glenmark Pharmaceuticals Ltd.; and is current consultant to ImunnosanT, Institute for Protein Design (PvP Biologics), Takeda Pharmaceutical Company, Ltd., Innovate Biopharmaceuticals, Inc., and Intrexon. Other authors have no disclosures.